FR2391733A1 - Antigene contre les tumeurs et son procede de preparation - Google Patents

Antigene contre les tumeurs et son procede de preparation

Info

Publication number
FR2391733A1
FR2391733A1 FR7713521A FR7713521A FR2391733A1 FR 2391733 A1 FR2391733 A1 FR 2391733A1 FR 7713521 A FR7713521 A FR 7713521A FR 7713521 A FR7713521 A FR 7713521A FR 2391733 A1 FR2391733 A1 FR 2391733A1
Authority
FR
France
Prior art keywords
preparation
against tumors
antigen against
tumors
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713521A
Other languages
English (en)
French (fr)
Other versions
FR2391733B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Publication of FR2391733A1 publication Critical patent/FR2391733A1/fr
Application granted granted Critical
Publication of FR2391733B1 publication Critical patent/FR2391733B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7713521A 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation Granted FR2391733A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619715 DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung

Publications (2)

Publication Number Publication Date
FR2391733A1 true FR2391733A1 (fr) 1978-12-22
FR2391733B1 FR2391733B1 (OSRAM) 1980-03-07

Family

ID=5977057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713521A Granted FR2391733A1 (fr) 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation

Country Status (17)

Country Link
JP (1) JPS52134011A (OSRAM)
AT (1) AT362497B (OSRAM)
AU (1) AU517395B2 (OSRAM)
BE (1) BE854269A (OSRAM)
CA (1) CA1077840A (OSRAM)
DE (1) DE2619715A1 (OSRAM)
DK (1) DK194477A (OSRAM)
FR (1) FR2391733A1 (OSRAM)
GB (1) GB1575545A (OSRAM)
IE (1) IE44943B1 (OSRAM)
IL (1) IL51989A (OSRAM)
IT (1) IT1074325B (OSRAM)
LU (1) LU77245A1 (OSRAM)
NL (1) NL7704724A (OSRAM)
NZ (1) NZ183980A (OSRAM)
SE (1) SE7705070L (OSRAM)
ZA (1) ZA772648B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087087A3 (en) * 1982-02-13 1983-10-19 Nippon Shinyaku Company, Limited A method of manufacturing biological active substance

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
US5145844A (en) * 1987-07-23 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain
US5030733A (en) * 1987-07-23 1991-07-09 Hoechst-Roussel Pharmaceticals Incorporated Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087087A3 (en) * 1982-02-13 1983-10-19 Nippon Shinyaku Company, Limited A method of manufacturing biological active substance

Also Published As

Publication number Publication date
NL7704724A (nl) 1977-11-08
JPS52134011A (en) 1977-11-09
BE854269A (fr) 1977-11-04
ATA313277A (de) 1980-10-15
CA1077840A (en) 1980-05-20
IT1074325B (it) 1985-04-20
LU77245A1 (OSRAM) 1977-12-13
SE7705070L (sv) 1977-11-05
FR2391733B1 (OSRAM) 1980-03-07
AT362497B (de) 1981-05-25
AU2481877A (en) 1978-11-09
IE44943L (en) 1977-11-04
DK194477A (da) 1977-11-05
ZA772648B (en) 1978-04-26
DE2619715A1 (de) 1977-11-24
IL51989A0 (en) 1977-07-31
NZ183980A (en) 1980-04-28
AU517395B2 (en) 1981-07-30
IE44943B1 (en) 1982-05-19
GB1575545A (en) 1980-09-24
IL51989A (en) 1980-01-31

Similar Documents

Publication Publication Date Title
FR2391733A1 (fr) Antigene contre les tumeurs et son procede de preparation
MY8500398A (en) Treatment of subsurface gas-bearing formation to reduce water production therefrom
ES477060A1 (es) Un metodo para la preparacion de interferon.
PT87086A (pt) Active specific immune suppression
ATE41924T1 (de) Vitamin d3-derivate mit einem substituierten in position 2.
PT85995A (en) Process for preparing a chimeric antibody with specifity to human tumor antigen
EP0547165A4 (OSRAM)
PT72275A (fr) Procede pour ameliorer la permeabilite des roches adapte ala production d'energie calorifique par geothermie haute energie
BG42004A3 (en) Method for preparing pyridyl compounds
JPS5788175A (en) Novel manufacture of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
PT72301B (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
FR2371460A1 (fr) Procede de preparation de kanamycine c et de ses derives desoxy
BG40144A3 (bg) Метод за получаване на 7-(1-имидазолилкарбонил)-3-(3-пиридил)- -1н,3н-пироло/1,2-с/тиазол
FR2362114A1 (fr) Nouvelles substances a action stimulatrice sur les b-recepteurs adrenergiques, procedes pour leur preparation et leur utilisation therapeutique
FR2427339A1 (fr) Nouveaux derives optiquement actifs d'oxazaphosphorine et leur procede de preparation
HUT47033A (en) Process for production of medical compositions against tumor
FR2398047A1 (fr) Procede de preparation d'a-cetocarbonamides n-substitues et produits obtenus par ce procede
PL214277A1 (pl) Sposob wytwarzania agregatow bakteryjnych komorek o zwiekszonej twardosci czastek
IL62988A0 (en) Germanium compounds,a process for the preparation thereof,a process for the preparation of a medicine using such a germanium compound for the treatment of cancer,as well as the shaped medicine thus formed and obtained
BG32859A3 (en) Method for obtaining of 6- aminorenicylin acid
BE882684A (fr) Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede
CA1273347C (OSRAM)
SU890688A1 (ru) Способ получения дитрет.-бутоксиметана
JPS5275594A (en) Method of pearl culture
FR2414919A1 (fr) Procede de preparation d'un complexe de substance active immunologique dirige contre la croissance maligne a partir de cellules

Legal Events

Date Code Title Description
ST Notification of lapse